SCM plant approved for BTG's varicose vein drug
The US Food and Drug Administration (FDA) has approved SCM Pharma to manufacture BTG’s varicose vein treatment from its Northumberland, UK facility.
The US Food and Drug Administration (FDA) has approved SCM Pharma to manufacture BTG’s varicose vein treatment from its Northumberland, UK facility.
Soon to merge CMO Patheon has increased solid dosage form production capacity at its site in the UK and posted an improved set of preliminary results for the financial year.
Unilife has agreed to supply customised drug delivery devices to Novartis in the fourth major deal inked in the last few months.
Asking qualified persons (QP) to certify that drug batches comply with manufacturing quality rules in destination EEA markets is unrealistic say groups commenting on proposed revisions to Annex 16 of the EU GMP guidelines.